Adalimumab 43835-0035
Product NDC
43835-0035- Manufacturer
- Novo Nordisk Production Belgium Sa
- Dosage Form
- Injection
- Product Type
- Drug For Further Processing
- Marketing Start
- July 1, 2023
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab-Bwwd | 100 mg/mL |
Packaging Options(2)
224 SYRINGE in 1 BOX (43835-0035-1) / .4 mL in 1 SYRINGE
170 SYRINGE in 1 BOX (43835-0035-2) / .4 mL in 1 SYRINGE